Sight Sciences, Inc.
NASDAQ:SGHTMedical - Devices
+$0.15 today
- Market cap
- $590.25M
- Beta
- 2.41
- P/E (TTM)
- -7.5
- EPS (TTM)
- -$0.69
Volume 0.38M
Average 0.25M
Returns on capital
Sight Sciences, Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-60.1%
avg -13.8%
ROIC
-35.4%
avg -74.9%
ROA
-33.3%
avg -59.3%
Analysis
ROA is currently the strongest return metric at -33.3% versus its period average of -59.3%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Paul Badawi | Co-Founder, President, Chief Executive Officer & Director | USD 1.01M | 50 | 6.09M | 11.20% |
Alison Perry Bauerlein | Chief Operating Officer | USD 676.65K | 45 | — | — |
Jeremy Hayden | Corporate Secretary | USD 584.25K | 56 | — | — |
Kashif Rashid | Chief Legal Officer & Corporate Secretary | USD 584.25K | 53 | 0 | <0.01% |
David Badawi | Co-Founder, Chief Technology Officer & Director | — | 55 | 1.98M | 3.63% |
James Rodberg | CFO & Treasurer | — | 42 | 216.83K | 0.40% |
Steve R. Tamayo Jr. | Vice President and Chief Ethics & Compliance Officer | — | — | — | — |
Kelly Petrucci | Senior Vice President of Market Access & Strategy | — | — | — | — |
Kelly Vaupel | Vice President of Marketing & Commercial Strategy, Interventional Glaucoma | — | — | — | — |
Sonia Clark | Vice President of People | — | — | — | — |
Brenton Taylor | Executive Vice President of Operations and R&D | — | 45 | 261.99K | 0.48% |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Oct 2, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
2
$184,756.96
Sells
36
$2.74M
Net Transaction Value
−$2.55M
Net selling
Most Active
Rodberg James
7 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Oct 2, 26Oct 2, 2026 | Bauerlein Alison Direct | Sell | $223.6K$223,626.78 |
| Oct 2, 26Oct 2, 2026 | Taylor Brenton Direct | Sell | $26.5K$26,452.76 |
| Oct 2, 26Oct 2, 2026 | Rodberg James Direct | Sell | $63.8K$63,812.42 |
| Oct 1, 26Oct 1, 2026 | Badawi David Direct | Sell | $70.6K$70,555.05 |
| Oct 1, 26Oct 1, 2026 | Badawi Paul Direct | Sell | $268.3K$268,330.00 |
| Jul 6, 26Jul 6, 2026 | HAYDEN JEREMY B. Direct | Sell | $70.1K$70,133.36 |
| Jul 6, 26Jul 6, 2026 | Badawi David Direct | Sell | $40.9K$40,858.34 |
| Jul 2, 26Jul 2, 2026 | Bauerlein Alison Direct | Sell | $129.6K$129,626.24 |
| Jul 2, 26Jul 2, 2026 | Rodberg James Direct | Sell | $37K$36,994.72 |
| Jul 1, 26Jul 1, 2026 | Taylor Brenton Direct | Sell | $15.3K$15,333.18 |
1–10 of 38
Summary
Insiders reported 2 buys worth $184,756.96 and 36 sells worth $2.74M over the last 12 months. That adds up to net selling of $2.55M. Rodberg James was the most active insider with 7 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +2.7% | +11.7% (4yr)2 analysts |
| Net Income | N/A | N/A | N/A | N/A2 analysts |
| EBIT | N/A | N/A | N/A | N/A2 analysts |
Analysis
Recent growth has been strongest in Revenue at +2.7% over three years. Forward estimates point to Revenue at +11.7% (4yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does Sight Sciences, Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
Questions
Management questions
Common questions about SGHT's management, answered from reported figures.
Who manages SGHT?
Sight Sciences, Inc. (SGHT) lists 11 active executives. The top listed executive is David Badawi, Co-Founder, Chief Technology Officer & Director.
Are SGHT insiders buying or selling?
Recent insider activity shows net selling of $13.70M.
Continue the stock analysis
Jump to another research area for this company.